We are live on ! Find out more
CSTL icon

Castle Biosciences
CSTL

57 hedge funds and large institutions have $88.1M invested in Castle Biosciences in 2019 Q3 according to their latest regulatory filings, with 57 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

28.52% more ownership

Funds ownership: 0% → 28.52% (+29%)

Holders
57
Holders Change
+57
Holders Change %
–
% of All Funds
1.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
57
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
+$16.5M
2
Goldman Sachs
Goldman Sachs
New York
+$6.69M
3
DCM
Driehaus Capital Management
Illinois
+$6.22M
4
WA
Wasatch Advisors
Utah
+$6.11M
5
BlackRock
BlackRock
New York
+$4.59M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Calamos Advisors
26
Calamos Advisors
Illinois
$572K +$702K +31,648 New
Citadel Advisors
27
Citadel Advisors
Florida
$555K +$680K +30,675 New
LCM
28
Laurion Capital Management
New York
$542K +$665K +29,986 New
DIM
29
DC Investments Management
Virginia
$507K +$622K +28,038 New
PCM
30
Perkins Capital Management
Minnesota
$505K +$619K +27,920 New
MWNA
31
Marshall Wace North America
New York
$444K +$544K +24,524 New
PCM
32
Prelude Capital Management
New York
$436K +$534K +24,101 New
FAM
33
Fred Alger Management
New York
$362K +$443K +20,000 New
Russell Investments Group
34
Russell Investments Group
United Kingdom
$313K +$384K +17,318 New
MPAM
35
Monarch Partners Asset Management
Massachusetts
$300K +$368K +16,590 New
Two Sigma Advisers
36
Two Sigma Advisers
New York
$297K +$364K +16,400 New
LCM
37
Landscape Capital Management
New Jersey
$256K +$313K +14,138 New
TAM
38
Tiverton Asset Management
Delaware
$211K +$258K +11,651 New
PPA
39
Parametric Portfolio Associates
Washington
$195K +$238K +10,756 New
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$104K +$128K +5,757 New
Wells Fargo
41
Wells Fargo
California
$65K +$79.8K +3,599 New
Morgan Stanley
42
Morgan Stanley
New York
$63K +$76.6K +3,454 New
UBS Group
43
UBS Group
Switzerland
$51K +$62.3K +2,810 New
Victory Capital Management
44
Victory Capital Management
Texas
$49K +$59.9K +2,702 New
EP
45
Elkfork Partners
Oregon
$47K +$58K +2,618 New
AIG
46
American International Group
New York
$42K +$51.7K +2,332 New
GHCM
47
Glen Harbor Capital Management
California
$39K +$47.8K +2,156 New
Bank of America
48
Bank of America
North Carolina
$32K +$38.9K +1,755 New
MCIM
49
Meadow Creek Investment Management
Georgia
$31K +$37.6K +1,694 New
JP Morgan Chase
50
JP Morgan Chase
New York
$22K +$26.8K +1,211 New
1
2
3

CSTL Hedge Fund Activity: Q3 2019 in Review

57 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Castle Biosciences (CSTL) for Q3 2019, worth a combined $88.1M.

Buyers outnumbered sellers: 57 funds opened new CSTL positions and 0 closed out — a net gain of 57 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was RTW Investments, opening a new position worth an estimated $16.5M.

  • 57 institutional investors held Castle Biosciences (CSTL) as of Q3 2019, up from 0 in Q2 2019.
  • Funds reported $88.1M of Castle Biosciences stock for Q3 2019.
  • 57 funds opened new Castle Biosciences positions in Q3 2019 and 0 closed out, a net change of +57 holders.
  • The largest Castle Biosciences buyer in Q3 2019 was RTW Investments, an estimated $16.5M added.

Based on aggregated 13F filings for Q3 2019.